Administration of CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, is feasible on a 7-day on, 7-day off schedule: a phase I pharmacokinetic and food effect study (Q45144611)
Jump to navigation
Jump to search
scientific article published in November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Administration of CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, is feasible on a 7-day on, 7-day off schedule: a phase I pharmacokinetic and food effect study |
scientific article published in November 2004 |
Statements
1 reference
Administration of CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, is feasible on a 7-day on, 7-day off schedule: a phase I pharmacokinetic and food effect study (English)
1 reference
Emiliano Calvo
1 reference
Anthony W Tolcher
1 reference
Lisa A Hammond
1 reference
Amita Patnaik
1 reference
Johan S de Bono
1 reference
Irene A Eiseman
1 reference
Stephen C Olson
1 reference
Peter F Lenehan
1 reference
Heather McCreery
1 reference
Patricia Lorusso
1 reference
Eric K Rowinsky
1 reference
1 November 2004
1 reference
1 reference
10
1 reference
21
1 reference
7112-7120
1 reference
Identifiers
1 reference
1 reference